Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The height of each bar represents the total number of risk variants in genetic regions, and the light gray color illustrates the number of risk variants associated with other diseasesList of the risk variants for severe COVID-19 and their associated diseases and biomarkersRisk variantsChrom.Diseases and biomarkersRelated systemrs455748331Atypical Hemolytic Uremic Syndrome (AHUS)Renal systemrs1471494593HyperglycinuriaNeuron systemrs76269623Heart disease, and Cardiac arrhythmia, Cardiovascular phenotype, and Congenital long QT syndromeCardiovascular systemrs617567664High level of white blood cell count procedure biomarkerImmune and hematopoietic systemsrs13168774 ,rs35652899, rs8176746, rs1508925045Asthma, and Systemic primary carnitine deficiency (CDSP)Respiratory and metabolic systemsrs18007957Alzheimer’s disease, Rheumatoid arthritis, KAPOSI Sarcoma, Diabetes mellitus type 1 and 2Neuron and metabolic systemsrs4958289Three-vessel disease (3VD)Cardiovascular systemrs5059229Diabetes mellitus Non-insulin-dependent, and high level of red blood cell countMetabolic systemrs126834939Mean Corpuscular Hemoglobin Concentration (MCHC)Hematopoietic systemrs6571529Venous thromboembolism, and low level of thyroid stimulating hormoneHematopoietic systemrs61270999Von Willebrand disease (VWD)Hematopoietic systemrs1225211Severe influenza, hypercholesterolemia, dengue fever, pneumonia, hepatoma, HIV-1 infectionImmune systemrs34481144, rs659804511Severe influenzaImmune systemrs14335923311SuntanIntegumentary systemsrs488321512Alzheimer’s diseaseNeuron systemrs66912Alzheimer’s disease, and Alpha-2-Macroglobulin polymorphismNeuron systemrs476702712Related to level of blood protein biomarkerHematopoietic systemrs8039305, rs76920898515HypertensionCirculatory systemsrs7271116517Ichthyosis and Lamellar ichthyosisIntegumentary systemsrs434317Alzheimer’s disease, high serum albumin level, Myocardial infarction, and renal tubular dysgenesis of genetic originNeuron and metabolic systemsrs434117Diabetes and hypertension, renal tubular dysgenesis of genetic originMetabolic and circulatory systemsrs42935819Alzheimer disease, hyperlipoproteinemiaNeuron systemrs140565519Diabetes mellitus non-insulin-dependent, Inflammatory bowel diseases, and Tuberculosis (TB)Immune and metabolic systemsrs210906919Idiopathic pulmonary fibrosisRespiratory systemrs1261049519Lung Diseases InterstitialRespiratory systemrs7495661519Rheumatoid arthritis, Cholangitis sclerosing, Ulcerative colitis, Crohn disease, Psoriasis, and Ankylosing spondylitisMetabolic and integumentary systemsrs13876343020Glomerular Filtration Rate, Vitamin D3 , Parathyroid hormone biomarkersHematopoietic and metabolic systemsrs207078821Cardiac arrhythmia, Atrial fibrillation, Long QT syndrome, Cardiovascular phenotype, Jervell and Lange-Nielsen syndrome 2Cardiovascular systemrs11436328721Severe influenza due to influenza A virus subtype H7N9Immune systemrs1170247521Prostate carcinomaReproductive systemrs1138594222ImmunodeficiencyImmune systemrs200553089, rs2042915990XImmunodeficiencyImmune systemrs2074192XCardiovascular diseases, Essential hypertensionCardiovascular and circulatory systemsrs2285666XDiabetes mellitus non-insulin-dependent, Hypertensive disease, Dyslipidemias, Orthostatic hypertensionMetabolic and circulatory systemsrs2106809XEssential HypertensionCirculatory systems

Source: Variant level: COVID-19 risk variants and disease association. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Computational network analysis of host genetic risk variants of severe COVID-19

Study design awaiting verification · Human Genomics · 2023

Original publication title

Computational network analysis of host genetic risk variants of severe COVID-19

Sakhaa B. Alsaedi; Katsuhiko Mineta; Xin Gao; Takashi Gojobori

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study highlights the importance of analyzing molecular interactions and pathways to understand the heterogeneous susceptibility of the host immune response to SARS-CoV-2. We propose new insights into pathogenicity analysis of infections by including genetic risk information as essential factors to predict future complications during and after infection. This approach may assist more precise clinical decisions and accurate treatment plans to reduce COVID-19 complications.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Genome-wide association studies have identified numerous human host genetic risk variants that play a substantial role in the host immune response to SARS-CoV-2. Although these genetic risk variants significantly increase the severity of COVID-19, their influence on body systems is poorly understood. Therefore, we aim to interpret the biological mechanisms and pathways associated with the genetic risk factors and immune responses in severe COVID-19. We perform a deep analysis of previously identified risk variants and infer the hidden interactions between their molecular networks through disease mapping and the similarity of the molecular functions between constructed networks.

Source: Background

Abstract: Results

We designed a four-stage computational workflow for systematic genetic analysis of the risk variants. We integrated the molecular profiles of the risk factors with associated diseases, then constructed protein: protein interaction networks. We identified 24 protein: protein interaction networks with 939 interactions derived from 109 filtered risk variants in 60 risk genes and 56 proteins. The majority of molecular functions, interactions and pathways are involved in immune responses; several interactions and pathways are related to the metabolic and cardiovascular systems, which could lead to multi-organ complications and dysfunction.

Source: Results

Abstract: Conclusions

This study highlights the importance of analyzing molecular interactions and pathways to understand the heterogeneous susceptibility of the host immune response to SARS-CoV-2. We propose new insights into pathogenicity analysis of infections by including genetic risk information as essential factors to predict future complications during and after infection. This approach may assist more precise clinical decisions and accurate treatment plans to reduce COVID-19 complications.

Source: Conclusions
Authors’ abstract

Background

Genome-wide association studies have identified numerous human host genetic risk variants that play a substantial role in the host immune response to SARS-CoV-2. Although these genetic risk variants significantly increase the severity of COVID-19, their influence on body systems is poorly understood. Therefore, we aim to interpret the biological mechanisms and pathways associated with the genetic risk factors and immune responses in severe COVID-19. We perform a deep analysis of previously identified risk variants and infer the hidden interactions between their molecular networks through disease mapping and the similarity of the molecular functions between constructed networks.

Results

We designed a four-stage computational workflow for systematic genetic analysis of the risk variants. We integrated the molecular profiles of the risk factors with associated diseases, then constructed protein: protein interaction networks. We identified 24 protein: protein interaction networks with 939 interactions derived from 109 filtered risk variants in 60 risk genes and 56 proteins. The majority of molecular functions, interactions and pathways are involved in immune responses; several interactions and pathways are related to the metabolic and cardiovascular systems, which could lead to multi-organ complications and dysfunction.

Conclusions

This study highlights the importance of analyzing molecular interactions and pathways to understand the heterogeneous susceptibility of the host immune response to SARS-CoV-2. We propose new insights into pathogenicity analysis of infections by including genetic risk information as essential factors to predict future complications during and after infection. This approach may assist more precise clinical decisions and accurate treatment plans to reduce COVID-19 complications.

Publication and source details

Original title: Computational network analysis of host genetic risk variants of severe COVID-19

Sakhaa B. Alsaedi; Katsuhiko Mineta; Xin Gao; Takashi Gojobori

Human Genomics · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.College of Computer Science and Engineering (CCSE), Taibah University, Medina, Saudi ArabiaKing Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR)FCC/1/1976-45-01BAS/1/1059-01Gao Xin Gojobori Takashi

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:16:26.206067+00:00

DOI: 10.1186/s40246-023-00454-y · PMC9977643